Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the test Early Onset Juvenile Parkinsonism Gene Panel is 21 days.

What are the prerequisites for the test Early Onset Juvenile Parkinsonism Gene Panel

  • Age of onset before 40 years
  • Family history of Parkinsonism
  • Presence of early-onset parkinsonism symptoms
  • Consultation with a genetic counselor or neurologist

What are the measure values for the test Early Onset Juvenile Parkinsonism Gene Panel

  • PARK2 (parkin): Normal range: 0-1.0
  • PINK1 (PTEN-induced putative kinase 1): Normal range: 0-1.0
  • PRKN (parkin): Normal range: 0-1.0
  • SLC18A2 (vesicular monoamine transporter 2): Normal range: 0-1.0

What does this test Early Onset Juvenile Parkinsonism Gene Panel identify?

  • Early Onset Juvenile Parkinsonism Gene Panel identifies mutations in genes associated with early onset juvenile parkinsonism.
  • These genes include PARK2, PINK1, DJ-1, and ATP13A2.
  • Mutations in these genes can lead to early onset parkinsonism, characterized by symptoms such as tremors, muscle rigidity, and difficulty with movement.
  • Testing for mutations in these genes can help confirm a diagnosis of early onset juvenile parkinsonism and guide treatment options.

Why is this test Early Onset Juvenile Parkinsonism Gene Panel taken?

Reasons for taking the Early Onset Juvenile Parkinsonism Gene Panel Test

  • Early diagnosis: The test helps in identifying genetic mutations associated with early onset juvenile Parkinsonism, allowing for early intervention and treatment.
  • Genetic counseling: Results from the test can provide valuable information for genetic counseling, helping individuals and families understand the risk of passing on the condition to future generations.
  • Treatment decisions: Knowing the specific genetic mutations present can help healthcare providers tailor treatment plans to individual patients, improving the effectiveness of therapy.
  • Research purposes: Results from the test can contribute to ongoing research efforts aimed at better understanding early onset juvenile Parkinsonism and developing new treatment options.

No FAQs available.

Customer Google Rating